Plasmonic Nanobubbles Enhance Efficacy and Selectivity of Chemotherapy Against Drug‐Resistant Cancer Cells
Source abstract
Abstract
Plasmonic nanobubbles, new multifunctional cellular nano-agents, are selectively generated in target cancer cells with a short near-infrared laser pulse. The enhanced cellular specificity and tunable transient nature of plasmonic nanobubbles provide fast, efficient and selective dual therapeutic effects: intracellular delivery of a drug and direct mechanical destruction of cells while sparing normal cells, and reduce drug dose and overcome drug-resistance of cancer cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Laser-Ablation Synthesis of Nanoparticles · Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (48)
Show source-provided references
1. 10.3322/caac.2007310.3322/caac.20073 ↗
2. 10.3342/ceo.2011.4.1.110.3342/ceo.2011.4.1.1 ↗
3. 10.1158/1078-0432.CCR-07-144110.1158/1078-0432.CCR-07-1441 ↗
4. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
5. 10.1021/nn100690m10.1021/nn100690m ↗
6. 10.1073/pnas.090970710710.1073/pnas.0909707107 ↗
7. 10.2147/NSA.S378810.2147/NSA.S3788 ↗
8. 10.1039/b806051g10.1039/b806051g ↗
9. Sokolov K. · Cancer Res. · 2003 · 63 · 1999
10. 10.1016/S0006-3495(03)75128-510.1016/S0006-3495(03)75128-5 ↗
11. 10.1021/nl050074e10.1021/nl050074e ↗
12. 10.1021/nl050127s10.1021/nl050127s ↗
13. 10.1146/annurev.bioeng.5.011303.12072310.1146/annurev.bioeng.5.011303.120723 ↗
14. 10.1016/j.addr.2009.11.00610.1016/j.addr.2009.11.006 ↗
15. 10.1002/smll.20100013410.1002/smll.201000134 ↗
16. 10.1364/OE.17.00253810.1364/OE.17.002538 ↗
17. 10.1021/nl900742510.1021/nl9007425 ↗
18. 10.1016/j.biomaterials.2011.11.01510.1016/j.biomaterials.2011.11.015 ↗
19. 10.1016/j.biomaterials.2010.06.03110.1016/j.biomaterials.2010.06.031 ↗
20. 10.2217/17435889.3.6.79710.2217/17435889.3.6.797 ↗
21. 10.1016/j.jconrel.2011.02.00610.1016/j.jconrel.2011.02.006 ↗
22. 10.1016/j.jconrel.2010.02.01210.1016/j.jconrel.2010.02.012 ↗
23. 10.1021/nn900469q10.1021/nn900469q ↗
24. 10.1016/j.canlet.2005.07.03110.1016/j.canlet.2005.07.031 ↗
25. 10.1016/j.jss.2010.10.03910.1016/j.jss.2010.10.039 ↗
26. 10.1021/nn100022210.1021/nn1000222 ↗
27. 10.2217/17435889.2.2.24110.2217/17435889.2.2.241 ↗
28. 10.1007/s00340-005-2036-610.1007/s00340-005-2036-6 ↗
29. 10.2217/17435889.3.5.64710.2217/17435889.3.5.647 ↗
30. 10.1002/lsm.2035910.1002/lsm.20359 ↗
31. 10.1038/8668410.1038/86684 ↗
32. 10.1007/BF0227669710.1007/BF02276697 ↗
33. Laser Institute of America. American national standard for safe use of lasers (ANSI Z136.1–2000)2000.
34. 10.1073/pnas.84.23.846310.1073/pnas.84.23.8463 ↗
35. 10.1038/nphys14810.1038/nphys148 ↗
36. 10.1016/S1040-8428(01)00179-210.1016/S1040-8428(01)00179-2 ↗
37. 10.3109/0265673880902930510.3109/02656738809029305 ↗
38. Kowal C. D. · Cancer Res. · 1979 · 39 · 2285
39. Gottesman M. M. · Cancer Res. · 1993 · 53 · 747
40. 10.1002/adma.20080092110.1002/adma.200800921 ↗
41. Fisher B. · Cancer Res. · 1992 · 52 · 2854
42. Urano M. · Cancer Res. · 1986 · 46 · 474
43. 10.2217/nnm.10.13310.2217/nnm.10.133 ↗
44. 10.1080/026567303100006504210.1080/0265673031000065042 ↗
45. 10.1021/ja802656d10.1021/ja802656d ↗
46. 10.1016/j.jconrel.2010.07.09510.1016/j.jconrel.2010.07.095 ↗
47. 10.1016/j.jconrel.2009.12.00610.1016/j.jconrel.2009.12.006 ↗
48. 10.1088/0957-4484/22/15/15560510.1088/0957-4484/22/15/155605 ↗